Back

Evaluation of long-term outcomes in ischemic and nonischemic dilated cardiomyopathies with ICD implantation (The single-center study)

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Arrhythmia management in patients with non-ischemic cardiomypathy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Ahmet Yetkin

Hacettepe University, Ankara (Turkiye)

5 More presentations in this session

Presentation thumbnail
EV ICD in non-ischemic cardiomyopathies
Doctor A. Carecci (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
High-voltage pulsed field ablation: a novel strategy for multiple redo ventricular tachycardia ablation in nonischemic cardiomyopathy patients
Doctor E. Chiarazzo (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Prediction of ventricular arrhythmias in non-ischemic cardiomyopathy using a 12-lead ECG-based machine learning model
Doctor M. Garcia-Montero (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic value of the NAPLES score in patients with dilated cardiomyopathy undergoing ICD implantation
Doctor M. Bilgin (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Segmental volume-weighted unipolar voltage: a novel parameter for localization of non-ischemic fibrosis and disease progression in dilated cardiomyopathy and ventricular arrythmias
Doctor Y. Kimura (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmia management in patients with non-ischemic cardiomypathy

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Dutch outcome in implantable cardioverter-defibrillator therapy extended follow up do it xl long term outcomes in a large primary prevention population
thumbnail
Congress Presentation
Comparative outcomes of ischemic and non-ischemic dilated cardiomyopathy in ICD recipients: a 30-Year retrospective analysis
thumbnail
Congress Presentation
Are patients with non-ischemic cardiomyopathy less deserving of primary prevention device implantation?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources